長建(01038.HK)升逾4% 傳洽售英國電力資產
《彭博》引述消息人士報道,由麥格理及KKR牽頭的財團正在收購,由長實集團(01113.HK)、長江基建(01038.HK)及電能實業(00006.HK)共同持有的英國電力資產UK Power Network,估值可能高達150億英鎊(約1,563億港元),雙方有可能會在未來數週內達成協議。
長建(01038.HK)股價今早曾跌1%低見47.35元近100天移動平均線見支持回升,午後升幅擴大,現報50.05元,升4.6%,收復10天,20天線及50天線,成交增至299萬股,高於20天日均成交。電能(00006.HK)微升0.8%報48.95元。長實集團(01113.HK)則跌0.8%報48.5元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.